FDA Approved Medical Products for:

Hemophilia B

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Coagulation Factor IX (human)
Trade Name
(Manufacturer Name)
AlphaNine®
(GRIFOLS)
Indication
The FDA has approved this product to be used in this manner.
For use as replacement therapy in patients with hemophilia B for the prevention and control of bleeding episodes, and during surgery to correct defective hemostasis.
More Information about this product Drug Information Portal

Generic Name Coagulation factor IX (recombinant), Fc fusion protein
Trade Name
(Manufacturer Name)
Alprolix
(Biogen Idec Inc.)
Indication
The FDA has approved this product to be used in this manner.
Adults and children with Hemophilia B for control and prevention of bleeding episodes, perioperative management, and routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
More Information about this product Drug Information Portal

Generic Name Coagulation Factor IX (Recombinant)
Trade Name
(Manufacturer Name)
BeneFix®
(Wyeth Pharmaceuticals, Inc.)
Indication
The FDA has approved this product to be used in this manner.
For the control and prevention of hemorrhagic episodes in patients with hemophilia B (congenital factor IX deficiency and Christmas disease), including control and prevention of bleeding in surgical settings.
More Information about this product Drug Information Portal

Generic Name Coagulation Factor IX
Trade Name
(Manufacturer Name)
Mononine®
(CSL Behring)
Indication
The FDA has approved this product to be used in this manner.
Prevention and control of bleeding in factor IX deficiency, also known as hemophilia B or Christmas disease.
More Information about this product Drug Information Portal

Generic Name Coagulation Factor VIIa (Recombinant)
Trade Name
(Manufacturer Name)
NovoSeven® RT
(Novo Nordisk, Inc.)
Indication
The FDA has approved this product to be used in this manner.
Treatment of bleeding episodes in patients with Factor VII Deficiency
More Information about this product Drug Information Portal

Generic Name Coagulation factor IX (recombinant)
Trade Name
(Manufacturer Name)
Rixubis
(Baxter Healthcare Corporation)
Indication
The FDA has approved this product to be used in this manner.
Adults with Hemophilia B for routine prophylaxis to prevent or reduce the frequency of bleeding episodes.
More Information about this product Drug Information Portal